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ABSTRACT 
Lung disease is one of the most important causes of high morbidity in preterm infants. In this 
work, we study a simple and easy to fabricate microfluidic device that demonstrates a great 
potential for blood oxygenation. A meander type architecture with double side vertical 
membrane arrangement has been selected as reference model to investigate the oxygenation 
process. The design criteria for the fabricated devices has been to maximize the oxygen 
saturation level while ensuring the physiological blood flow in order to avoid thrombus 
formation and channel blockage during operation. A mathematical model for the oxygen 
transfer has been developed and validated by the experimental study. The obtained results 
demonstrate that blood was successfully oxygenated up to approximately 98% of O2 
saturation and that the oxygen transfer rate at 1 mL/min blood flow rate was approximately 92 
mL/min·m2. Finally, a sensitivity analysis of the key parameters, i.e. size of the channel, oxygen 
concentration in the gas phase and oxygen permeation properties of the membrane, is carried 
out to discuss the performance limits and to settle the guidelines for future developments.  
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Introduction 
The urge of new technologies for blood oxygenation in lung assist devices appeared 
as a result of a high morbidity caused by pulmonary disorders. Lung transplantation is 
nowadays the only available clinical therapy for adults with the end-stage of chronic 
lung disease. However, the regular time that patients need to wait for the organ 
transplantation is 2 years, and approximately 10% of them are dying while waiting for 
the organ to be available. Moreover, preterm infants who are born younger than 32 
weeks are at extremely high risk of suffering from severe respiratory problems as a 
result of smaller available surface area for gas exchange or due to the poor diffusion 
properties of their lung’s membrane [1]. The lung transplant cannot be executed due to 
the fact that implanted organs in infants do not grow with them. Mechanical ventilation 
is a commonly used technique for delivering sufficient amount of oxygen; however, 
some serious complications may occur for small lung tissue which is under 
development. These factors drew the attention to the development of a new 
technology which will assist in blood oxygenation. 
Along the last years, a biomimetic microfluidic technology has been developed and 
reported by several authors [1-6] and recently reviewed by J. Potkay [7-8] for the 
application of lung assist device. In these microchips blood flows through vascular 
microchannels which are physically separated from an oxygen stream by a gas 
permeable membrane. Oxygen permeates through the membrane and enters the blood 
first as dissolved oxygen in plasma and later becomes bonded to haemoglobin (Hb), 
which implies that the mass transfer resistance is mainly located in the liquid phase for 
the vast majority of the oxygenation tests. When small blood channel diameters (lower 
than 30 μm) and thick membranes (thickness higher than 50 μm) are considered, the 
membrane resistance may be comparable to the offered by the liquid phase or even 
dominant. The possible benefits of such microfluidic chips include: 1) small surface area 
and priming volume which leads to a decrease of the device dimensions, 2) improved 
biocompatibility thanks to the blood chamber architecture that mimics the structure of 
a natural lung so cells and platelets experience pressures, shear stresses and branching 
angles similar to a human organ, 3) increased gas exchange capacity that enables the 
respiratory support for patients who are not only in rest [7].  
Nowadays researchers are mastering the design and fabrication of lung assist devices in 
the form of a microfluidic chip, the so called microfluidic artificial lungs (μALs). Various 
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materials and morphologies of membranes integrated in the microfluidic devices were 
examined by the group of Prof. Vacanti at the Centre of Regenerative Medicine, Massachusetts 
General Hospital, USA. Dense and porous polycarbonate (PC) and different silicone 
membranes were taken into account and the oxygen transfer rate obtained for all the 
membranes was similar even at various thicknesses [2, 3]. Potkay et al. focused their efforts on 
the optimization of the liquid chamber dimensions, for very shallow blood channel depths, i.e. 
20 μm and 10 μm [9]. Recently, flat two-dimensional μALs stacked in parallel with a capillary 
height of 30 μm has been demonstrated as a trade-off to maximize oxygenation performance 
and reduce the number of layers that are needed for a clinically-relevant device [8]. The same 
group developed a new manufacturing approach for scaling up based on roll to roll polymer 
sheet processing [6]. In particular, a μAL with a four-layer structure (blood layer 10 µm height 
/membrane 66 µm thick/air layer/capping layer) was assembled by rolling a cylindrical 
substrate over the patterned PDMS substrate. The in vitro experiments were performed 
resulting in high gas exchange rates. Nevertheless, the authors concluded that scaling up the 
device could be challenging due to the fabrication limitations for large area devices.  
It was noticed that the shallower the blood channels the shorter the pathway that 
oxygen has to pass to bind to Hb and thus the fastest the blood oxygenation. However, 
extremely elevated pressure drop and shear stress were observed on the liquid side 
which could lead to chamber collapse or channel blockage by red blood cells (RBCs) due 
to the non-homogenous blood flow, i.e. blood accumulation in certain zones of the 
structure. Consequently, thanks to the development of soft-lithography, a large variety 
of more complicated structures have been examined by different authors. Liquid 
chamber architectures with branching channels, imitating the natural lung, that obeyed 
bifurcation theory were designed by Kniazeva et al.[10, 11]. Especially, Hoganson et al. 
presented an outstanding liquid chamber design in terms of physiological blood flow. 
The proposed system possessed various channel depths along the entire structure, i.e. 
from 700 μm to 100 μm, and branching architecture [12]. This procedure significantly 
decreased pressure drop and shear stress along the chamber. Selvaganapathy et al. 
fabricated interesting stainless steel reinforced composite silicone membranes to 
improve gas exchange performance. The composite membrane consisted of ultra-thin 
stainless-steel mesh embedded in PDMS that demonstrated high stability, low 
deformation under pressure and high gas exchange [13].  
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Essential points that need to be further studied are the optimization of liquid 
chamber geometries easy to fabricate and suitable for scaling up that keep 
cardiovascular parameters and blood specifications in desired range; and, the creation 
of the right balance between chip mechanical stability and good oxygenation 
performance. Crucial restrictions for the liquid side that need to be obeyed in order to 
keep the blood at physiological level include three main aspects: i) shear stress should 
not exceed the normal range in the human vascular system of 0.1 to 7 N/m2 [12], ii) 
pressure drop, the arteriovenous pressure difference for neonates is in the range of 
26.7 to 79.9 mbar [13] iii) the distribution of blood flow should be homogenous [14-15]. 
Assuming an extracorporeal bypass volume of 30 mL·kg-1·min-1 (i.e. 10% of the output 
volume is circulating extra-corporeally), it was estimated that to increase the oxygen 
saturation in blood from 70% to 100%, the oxygen transfer rate in a microdevice should 
be 1.9 mL·kg-1·min-1 [1]. 
Unlike previously described µALs, a meander type architecture with oxygen and 
blood channels in the same plane is herein investigated for the first time. The gas-liquid 
separating walls constitute a gas permeation membrane. Such geometrical 
conformation provides double side gas diffusion, i.e. duplicate the gas exchange area, 
thereby doubling gas exchange; which benefits the compactness of the system. Above 
all, the main advantage of the single layer, meandering structure is that it notably 
simplifies manufacturing process by removing the need to fabricate separate blood, 
membrane, and gas layers which decreases the probability of imperfection in bonding, 
membrane morphology or device structure.  
In this work, a simple and easy to fabricate meander type microfluidic device for 
blood oxygenation is studied. First, the fluid dynamics of the conceptual microdevice 
are analysed and the physiological conditions are ensured. Next, the fabrication 
procedure for a meander type architecture with oxygen and blood channels in the same 
plane, where the separating walls constitute a permeation membrane will be described, 
followed by an outline of the experimental methodology. The oxygenation performance 
of the obtained microdevices is evaluated and compared to that predicted by a 
mathematical model. Finally, a sensitivity analysis for width of the microchannel, 
oxygen concentration in the gas phase and oxygen permeation properties of the 
membrane is carried out to identify the parameters that exert the strongest influence. 
A basic metrics comparison with previous published results and guidelines for the 
future development of an improved oxygenator structure for preterm infants are given. 
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Numerical and experimental methods 
Design and computational fluid dynamics models 
In the proposed design (see Figure 1), the liquid chamber (red colour) is 
surrounded by gas channels (blue colour) from both sides and separated by a gas-
permeable PDMS membrane. The entire PDMS structure is closed by a glass slide at the 
bottom. The total surface area for gas exchange is thus the lateral area of one meander 
unit multiplied by the number of units and the number of branches of the entire 
structure (see Figure 1 for the entire design). The PDMS wall between the gas channel 
and the liquid channel is the actual membrane thickness. Therefore, the gas-liquid 
contact area, i.e. the membrane surface, depends on the depth and the length of the 
channels. A larger channel depth is beneficial because it increases the gas-liquid contact 
area, which is favourable for the oxygen saturation level. 
The presented configuration requires a manufacturing process that does not 
require a separate step for the fabrication of the membrane, which usually includes 
peeling off of a thin film from a support (e.g. a Si wafer), a technique commonly used in 
the microfabrication of membranes for artificial microfluidic oxygenators [7]. Instead, 
the entire structure is embedded in the same layer. Moreover, the oxygen enters the 
blood channel from both sides, giving double side diffusion (see the magnification in 
Figure 1) which increases blood oxygenation per unit of length. Considering that the 
oxygen comes from the sides of the channel instead of from the top of it, as it is 
commonly done, narrowing of the liquid channel will increase the O2 transfer rate and 
will decrease the actual dimensions of the chip because the same surface area will be 
loaded in a smaller chip footprint. On the other hand, it should be noted that the 
channels should not be made too narrow, to keep low the pressure drop and shear 
stress for a given flow rate. In this study the balance between these parameters has 
been taken into account in the selection of the key feature sizes. 
Numerical modelling was used to drive the design of the artificial capillaries in 
the proposed meandering channel gas-liquid contactor, with an emphasis on 
homogenous liquid flow, low pressure drop and shear stress as well as high surface to 
volume ratio. The liquid flow distribution in the microchannels was numerically solved 
in 2D using COMSOL® Multiphysics 5.0 software. In order to describe the flow of blood 
along the designed microchannel, laminar flow physics were adapted for blood inside 
the liquid chamber geometry. The momentum conservation for laminar flow of 
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incompressible fluids (Equation 1) was solved together with the mass conservation 
(Equation 2), using the Navier-Stokes equations:   
𝜌𝜌(𝐮𝐮 ∙ ∇)𝐮𝐮 = ∇ ∙ �−𝑝𝑝𝐈𝐈 + 𝜇𝜇(∇𝐮𝐮 + (∇𝐮𝐮)𝑇𝑇) − 2
3
𝜇𝜇(∇ ∙ 𝐮𝐮)𝐈𝐈� + 𝐅𝐅     (1) 
 
∇ ∙ (𝜌𝜌𝐮𝐮) = 0           (2) 
Where, ρ is the blood density, u stands for the flow velocity vector field, p is the 
pressure, μ is the blood viscosity and superscript T is transposed of a matrix. In Equation 
1, the terms on the left side are acceleration forces and on the right side pressure 
gradient and viscous forces. Following assumptions have been made: no slip condition 
on the walls of the liquid chamber geometry; u = 0, no back-flow permitted, the flow 
direction was defined as normal to the chamber inlet and outlet, and the outlet 
pressure was set at 1 atm. The set of governing equations was solved using a finite 
element method. The convergence criterion was based on the residual error in the 
momentum equation, which was set to 10-3. 
A variety of meandering architectures were examined in order to find the 
optimum one in terms of the criteria previously mentioned. The chosen structure has a 
liquid channel width of 400 μm, gas channel width of 100 μm and the spacing in 
between (the membrane thickness) of 120 μm. The depth of the entire structure is 
equal to 100 μm. It is made of 19 meandering units and 9 branches loaded on a surface 
of 35.04 cm2 of total chip footprint. Table 1 shows the main parameters of the proposed 
meander type chip. 
The final model structure consisted of more than 40000 triangular elements 
defining a structured mesh with an edge length in the range 0.04-0.005 cm. Figure 2 
shows the results of the fluid dynamic modelling of the liquid chamber for (A) liquid 
flow velocity, (B) pressure drop and (C) shear stress, respectively, at 1 mL/min blood 
flow rate. It is visible that the liquid flow profile is homogenous and that the liquid 
enters all the branches with the same velocity. This ensures that in the proposed 
structure there will not be a risk of dead zones or mass accumulation. The 
mathematically calculated ΔP and shear stress for 1 mL/min blood flow rate is equal to 
16.9 mbar and 3.42 N/m2, respectively indicating that there will not be a risk of 
thrombus formation inside the liquid channels. The experimental measurements of 
pressure drop in the liquid chamber agree well with the calculated values, i.e. 18.4 
mbar vs. 16.9 mbar (see Figure S1 in the Supplementary Material for more details). 
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Moreover, Mockros and Cook [16]: analysed the shear-induced and material induced 
blood trauma factor, TF,S and TF,M, respectively from equation (3) and (4)  
            𝑇𝑇𝐹𝐹,𝑆𝑆 = 𝜏𝜏𝑎𝑎𝑎𝑎𝑎𝑎2 − 900𝑡𝑡𝑅𝑅 − 225                                                                                          (3) 
            𝑇𝑇𝐹𝐹,𝑀𝑀 = 𝜏𝜏𝑎𝑎𝑎𝑎𝑎𝑎2 + 2𝑡𝑡𝑅𝑅 − 16                                                                                              (4) 
 
Where, τavg is the average shear stress that the blood is experiencing and tR is the residence 
time of blood in the device. The TF,S should be lower than zero and TF,M should be greater than 
zero to avoid blood trauma. In the case of our oxygenator device the TF,S is equal to -250.9 and 
-473.4 for 0.1 and 1 mL/min blood flow rate, respectively. These values show that there was no 
shear-induced platelet activation. On the other hand, TF,M is equal to -15.8 and -3.73 for 0.1 
and 1 mL/min, respectively. These values indicate that the material-induced blood trauma due 
to stagnation was present. Experimentally, we did not record any accumulation of activated 
coagulation factors in the structure, mainly due to the use of EDTA as anticoagulant, as 
described in the oxygenation set-up section. 
 
Oxygen mass balance 
The mass balance and transport equation for oxygen species in blood was 
developed from a standard convection-diffusion mass transfer expression [11, 17-18]. 
When blood enters the microchannel, the partial pressure of dissolved oxygen is low 
(see Figure 3B). As the blood flows along the channel, oxygen diffuses out of the gas 
side of the chip, across the membrane and into the blood, dissolving in blood plasma 
and then diffusing to and into red blood cells and binding to haemoglobin.  
The oxygen pressure on the gas side of the device has been considered constant 
due to: i) the resistance to diffusion on the gas side of the device is negligible compared 
to that of the membrane and blood, and ii) its supply is higher than its gas exchange 
rate. These assumptions are also made in the simple closed-form model developed by 
Potkay [19] for oxygen diffusion; who considered, unlike in this work, that the partial 
pressure of gases in blood does not vary along the width and height of the liquid 
channel. 
The partial differential equation that governs the oxygen transport in the blood 
under steady state operation can be expressed as follows [15]:  
 u ∙ ∇𝑃𝑃𝑂𝑂2 = 𝐷𝐷𝑒𝑒𝑒𝑒𝑒𝑒 ∙ ∇2𝑃𝑃𝑂𝑂2        (5) 
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Where, Deff is the effective diffusivity of oxygen in blood which incorporates the 
effects of oxygen uptake by haemoglobin introduced first by Mockros and Leonard [17]. 
Such effective diffusivity is calculated from Equations 6 to 8: 
𝐷𝐷𝑒𝑒𝑒𝑒𝑒𝑒 = 𝐷𝐷𝑏𝑏1+𝜆𝜆(𝑃𝑃)          (6) 
Where, Db is the O2 diffusion coefficient in plasma and λ(P) is the mathematical 
term developed to account O2 bound to Hb. It is expressed as a function of oxygen 
concentration in haemoglobin, denoted as [Hb], according to Equation 7, being α the 
oxygen solubility in plasma: 
𝜆𝜆(𝑃𝑃) = 1.34 [𝐻𝐻𝐻𝐻]∙𝑆𝑆′𝑂𝑂2
𝛼𝛼
        (7) 
And S’O2 is: 
𝑆𝑆′𝑂𝑂2 = 𝑛𝑛(𝑃𝑃50)𝑛𝑛∙𝑃𝑃𝑂𝑂2𝑛𝑛−1
�𝑃𝑃50
𝑛𝑛 +𝑃𝑃𝑂𝑂2
𝑛𝑛 �
2         (8) 
and can be derived from the oxygen-binding equilibrium of Hb known as the 
Hill’s equation [17, 20]: 
 
SO2= �PO2P50�n1+�PO2P50�n         (9) 
 
where: SO2 is the fractional oxygen saturation, n is the number of binding sites of 
haemoglobin (called the Hill coefficient), and P50 is the partial pressure of oxygen when 
blood is 50% saturated. The parameter n of the Hill equation is taken to be constant for 
a particular blood specie, being n=2.85 for bovine blood. This number was also 
corroborated by Zhang et al. [20] fitting the experimental data of saturation to the Hill 
curve obtaining a value of n=2.84 and P50=38.7 mbar. The parameter P50 [mbar] 
depends upon pH and temperature, T, according to Equation 10, for bovine blood [17]: 
𝑃𝑃50 = 38.7 ∗ 10(−0.41)(7.4−𝑝𝑝𝐻𝐻) ∗ 10(−0.024)(37−𝑇𝑇)    (10) 
Rearranging the above equations, the effective diffusivity is expressed as follows: 
𝐷𝐷𝑒𝑒𝑒𝑒𝑒𝑒 = 𝐷𝐷𝑏𝑏
1+
1.34[𝐻𝐻𝑏𝑏]∙𝑛𝑛(𝑃𝑃50)𝑛𝑛∙�𝑃𝑃𝑂𝑂2�𝑛𝑛−1
𝛼𝛼�𝑃𝑃50
𝑛𝑛 +𝑃𝑃𝑂𝑂2
𝑛𝑛 �
2
        (11) 
The coupling between the oxygen mass balance in the plasma and the 
membrane surface is obtained as a boundary condition in the liquid’s mass balance. 
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This condition sets the flux of oxygen at the boundary equal to the permeation rate 
through the PDMS membrane, JO2, and is presented below [21]: 
𝐽𝐽𝑂𝑂2 = 𝐷𝐷𝑚𝑚 ∙ 𝛼𝛼𝑚𝑚 ∙ �𝑃𝑃𝐺𝐺,𝑂𝑂2 − 𝑃𝑃𝑂𝑂2,𝑤𝑤𝑎𝑎𝑤𝑤𝑤𝑤� ∙ 1𝑡𝑡𝑚𝑚     (12) 
where Dm is the diffusion coefficient for oxygen in the PDMS membrane, αm is 
the solubility of oxygen in the PDMS membrane, tm is the thickness of the membrane, 
PO2,wall is the partial pressure of dissolved oxygen at the thin film wall, PG,O2 is the partial 
pressure of oxygen in the gas side. The product of Dm and αm corresponds to the 
oxygen permeability, denoted as Perm, of the PDMS membrane. Table 2 shows the 
main constant parameters which are used in the calculations carried out in this work to 
evaluate the experimental and simulated oxygenation performance. 
Microfabrication and Testing 
Microdevice fabrication 
The microfluidic device used in this work was made of Polydimethylsiloxane 
(PDMS; Sylgard 184 Dow Corning, Midland, MI) which was chosen because of its optical 
transparency, biocompatibility and high O2 and CO2 permeability (see Table 2) [22, 26]. 
Furthermore, its highly elastic properties enable that it can be easily released from 
moulds and conform to surfaces. 
The meander architecture was fabricated using a procedure reported previously 
by several authors [2, 11, 23-24]. Briefly, the masters were prepared by standard 
photolithography to create a pattern in SU-8 photoresist (SU-8 50 DE MicroChem) 
deposited on a flat silicon substrate. PDMS pre-polymer and curing agent were 
thoroughly mixed in a ratio 10:1 and placed in a desiccator for degassing. PDMS was 
poured on the masters and placed in an oven for 45 min at 80oC. The mould was peeled 
off from the silicon wafer, cut to the required size and punched for inlets and outlets by 
a round punch (TiN Coated Round Punch, Syneo). The fabricated chamber was 
immersed in isopropanol (Sigma Aldrich) and placed in an ultrasound bath for 
approximately 2 minutes in order to remove any possible dust that could be attached to 
the inside of the channels, or PDMS debris inside the punched holes. The fabricated 
PDMS platform was placed inside an oxygen plasma chamber (Diener electronic, 
Plasma-surface-technology) operating at 0.4 mbar, 120 W and 50% of O2 during 50 sec, 
in order to activate the surface, which enabled connecting the PDMS platform to glass 
[25]. The chamber and the glass slide were connected and placed in an oven at 85oC for 
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1 hour. Next, metallic pins in the form of bridges were inserted at the gas inlets of each 
branch in order to supply gas to each liquid unit and arm. The volume of the metallic 
pins for each microdevice is circa 17 µL. 
Microfluidic device characteristics 
The liquid chamber architecture enabled uniform blood flow through the 
meandering liquid microchannels while supplying pure O2 permeating through a PDMS 
membrane from both lateral sides of the chamber. The gas or liquid was introduced to 
the chip by Tygon microbore tubing (0.020” x 0.060” OD, Cole-Parmer, The 
Netherlands) and precision stainless steel dispense tip (0.010” ID, 0.020 OD, 45o bend, 
Nordson, The Netherlands). The bridges which were connecting the gas channels were 
made of the same precision stainless steel dispense tips (see Figure 4C). Figure 4 gives 
SEM images (A, B) and a photograph of a meandering microfluidic device with coloured 
liquid (red colour) and gas (green colour) channels for better visualisation (Figure C and 
Figure 4C1). The image indicates that the filling of the liquid channels was homogenous 
and well distributed without dead volumes. It is also important to note that in this 
architectural conformation there was no risk of membrane deflection or detachment 
since the membrane is embedded and structurally integrated in the chamber. The 
fabricated devices were tested under the experimental conditions described above. No 
leak or chamber collapse was observed. The device was able to operate for at least 8 
hours at a blood flow rate of 1 mL/min without channel collapse or blockage. Three 
identical meander type microfluidic devices were fabricated and tested. For all of them, 
the thickness of the PDMS mould for the mixed PDMS compartment was approximately 
0.8-1 cm and the chip footprint was equal to 35 cm2, making it a very compact system.  
Oxygenation set-up 
The device performance was tested by measuring the blood oxygenation in the 
experimental system presented in Figure 5. All the oxygenation experiments were 
carried out with sheep blood obtained from Faculty of Veterinary at University of 
Zaragoza. The blood samples were collected and transferred into 10 mL plastic tubes 
(Becton Dickinson B.V., Spain) with Ethylenediaminetetraacetic acid (EDTA) as 
anticoagulant in a concentration of 1.5 mg/mL. The haemoglobin concentration of each 
batch was measured by gasometry (Vet abc, Animal Blood Counter). Blood was stored 
under refrigeration at 4oC during a maximum period before essays of 24 hours.  
Obtained blood was a venous blood with an oxygenation of approximately 98%. 
Therefore, it was necessary to deoxygenate it prior to the oxygenation experiment. 
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First, 50 mL of blood was transferred into a glass bottle and placed on a stirring plate 
inside a climatic chamber in order to maintain a temperature of 37ºC. A mixture of air 
and nitrogen with 7.8% of O2 was bubbled directly to the blood for approximately 1 
hour in order to decrease the O2 blood saturation down to approximately 70%. 
Afterwards, the deoxygenated blood was transferred into a 50 mL syringe (Becton 
Dickinson B.V., Spain) and placed in a syringe pump (Harvard Apparatus, Spain). The 
experiments were performed at blood flow rates ranging from 0.1 to 1 mL·min-1. A 
pressure transducer (Panasonic, DP2-41E) was placed right after the syringe pump to 
evaluate the pressure drop across the entire system, taking into account the device 
itself, piping and metallic pins. Next, the gas chamber was purged with pure oxygen 
while deoxygenated blood entered the microdevice from the liquid chamber side. The 
initial outlet blood stream was discarded by pumping it to the waste reservoir to ensure 
steady state conditions in the analysed sample (after approximately 2 minutes of blood 
flowing through the system, depending on the blood flow rate). The oxygenated blood 
was collected in a glass bottle hermetically sealed in which a pH electrode (Hamilton, 
Slimtrode 238150, Switzerland) and a dissolved oxygen electrode, type oximeter 
(ThermoFisher Scientific, Orion Star A223), were immersed. Before each set of 
experiments, a control sample measurement was performed by passing the blood 
throughout the experimental system without oxygenating it (i.e. O2 mass flow 
controller and gas outlet closed), in order to ensure that no leaks are present in the 
system, and that there is no blood oxygenation by the oxygen stored in the head space 
of the blood collecting bottle.  
Three repetitions, one for each identical meander device, were performed at 
distinctive blood flow rates. The concentration of haemoglobin slightly differed from 
sample to sample. Therefore, for each experiment, the Hb concentration was measured 
by gasometry. The main blood inlet parameters for each oxygenation experiment are 
shown in Table 3 (see Table S1 in the Supplementary Material for the output blood 
values and oxygen transfer rates estimated for the three identical devices). 
The O2 transfer rates, O2transf (mol·m-2·s-1), through the membrane was 
calculated according to the following Equation 13: 
𝑂𝑂2𝑡𝑡𝑡𝑡𝑎𝑎𝑛𝑛𝑡𝑡𝑒𝑒 = 𝛼𝛼 ∙ ∆𝑃𝑃𝑂𝑂2 + 𝐻𝐻𝐻𝐻𝐻𝐻 ∙ ∆𝑆𝑆𝑂𝑂2 ∙ [𝐻𝐻𝐻𝐻]𝑆𝑆𝑆𝑆 ∙ 𝑄𝑄 (13) 
Where: α is the solubility coefficient of O2 in blood plasma (see Table 2), ΔPO2 
[mbar] is the difference between the outlet and inlet values of partial pressure that 
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corresponds to the dissolved oxygen measured. Thus, the term α·ΔPO2 corresponds to 
the concentration of dissolved oxygen in plasma [1]. ΔSO2 [-] is the increment in oxygen 
saturation in blood, Hbs is the O2 binding capacity of haemoglobin (see Table 2), [Hb] is 
the haemoglobin concentration in blood. The term Hbs·ΔSO2·[Hb] corresponds to the 
concentration of oxygen in blood that is bound to haemoglobin [1]. Q is the blood flow 
rate and SA is the gas exchange surface area (see Supplementary Material for 
calculation details). 
Results and Discussion 
In Figure 6 we show the simulated oxygen concentration profiles along the 
meander type geometry for two liquid flow rates: A) 0.1 mL/min (Re=0.06) and B) 1 
mL/min (Re=0.6) with their respective magnifications. As was expected, higher values of 
oxygen concentration are obtained at lower blood flow rates. Moreover, it can be 
observed that the highest values of the dissolved oxygen concentration are localized 
near the membrane wall. Figure 7 illustrates how experimental and simulated results 
on the total O2 transfer rate compare. The experimental and theoretical values are in 
very good agreement. The highest relative error of the oxygen transfer rate between 
experiment and model is present in the case of the highest blood flow rate, i.e. 1 
mL/min and is approximately 15%. 
Figure 8 shows the oxygen transfer rate at different blood flow rates in 
comparison to results of the leading research groups. The oxygenation obtained by 
Potkay et al. [9] results from the shallow channel depth of the liquid chamber, i.e. 10 
μm or 20 μm which suffered from a high pressure drop on the liquid side, 253 mbar and 
160 mbar, respectively. The O2 transfer rate achieved by Kniazeva et al. [10] with a 
branching architecture, equal to 223 mL/min·m2 outperforms our results of 92 
mL/min·m2. This could be expected considering that the main transfer limitations occur 
on the liquid side and the channel depth in that case was 50 μm compared to a 
diffusion distance in our channels of 400 μm surrounded by a membrane on both sides. 
This means that in the meander device design we have a 4 times higher diffusion 
distance on the liquid side, compared to the branching architecture device, however 
the oxygen transfer rate is only 2.8 times lower. These results show that the simple 
meander design, with double side membrane, could be improved by narrowing the 
channels to achieve higher oxygenation. Using the validated model, we have pursued a 
sensitivity analysis to optimize the parameters in the meander design. 
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Sensitivity analysis of key parameters on oxygenation performance 
The effect of the following parameters: 1) oxygen concentration from the source 
gas, 2) membrane thickness, and 3) liquid channel width, on the overall performance of 
the fabricated microdevices was studied. The target of the parameter sensitivity study 
was to quantify the impact of a relative change of the considered parameters on the 
overall O2 transfer rate.  
Figure 9A shows the effect of the oxygen concentration in the source gas on the 
blood oxygenation, keeping constant the PDMS membrane thickness (120 μm) and 
channel width (400 μm). Three oxygen concentrations were simulated: 100%, 60% and 
21% of O2 entering the system from the gas side. As was expected, the highest ΔSO2 and 
fastest O2 transfer is observed in case of pure oxygen, due to the highest driving force 
for permeation. This effect is more important in the case of higher flow, where an 
increase from 21% to pure oxygen multiplies the O2 transfer rate by nearly 100%. Thus, 
it would be advisable to use pure oxygen to boost the oxygenation process. Next, the 
influence of the membrane thickness on the final performance of the chip is illustrated 
in Figure 9B, keeping constant the channel width (400 μm) and using pure oxygen in the 
gas phase. The highest oxygenation was obtained in case of implementing the thinnest 
membrane due to the minimized resistance to gas diffusion through PDMS and the 
higher PO2,wall values (partial pressure of oxygen at the membrane wall in contact with 
blood). This effect is more pronounced in the case of shorter residence time when not 
only the mass transfer limitations in the liquid phase occur but also there is a mass 
transfer resistance in the membrane. The computer simulation presented in Figure 9C 
shows the modification of the oxygen transfer rate and SO2 for 120 μm PDMS 
membrane and pure oxygen as a function of channel width, keeping the cross section of 
the channels constant, i.e. the same total volume of the liquid chamber to maintain the 
residence time constant for a given flow rate. Four channel widths were simulated: 400 
μm, 300 μm, 200 μm, and 100 μm. As it was expected, the thinner the channel the 
higher O2 transfer rate due to the shorter diffusion distance to bind to Hb. 
According to the simulated results, a weighted average factor was calculated 
assuming linear dependence to illustrate the impact of the different key parameters 
(expressed in dimensionless form) on the oxygen saturation values i.e. ΔSO2, also 
expressed in dimensionless form. The calculation of such weight averaged sensitivity for 
oxygen concentration in the source gas is shown below: 
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𝑎𝑎 = [ΔSO2]100[ΔSO2]𝑚𝑚𝑚𝑚𝑚𝑚− [ΔSO2]60[ΔSO2]𝑚𝑚𝑚𝑚𝑚𝑚100
100
−
60
100
                                                                                                (13)  
 
Where: [ΔSO2]100 and [ΔSO2]60 are mathematically oxygen saturation values 
obtained for a standard blood flow rate equal to 0.5 mL/min at the 100% O2 and 60% 
O2 in the source gas, respectively; and [ΔSO2]max corresponds to 100% oxygen saturation 
level at the outlet. The same calculation was repeated for membrane thickness and 
blood channel width variables. Thus, the estimated weight averaged sensitivity values 
are: 0.5, 0.25 and 0.1 for inlet oxygen concentration, membrane thickness and liquid 
channel width respectively.  
The parametric sensitivity analysis showed that the factor with the highest 
impact on the blood oxygenation in the fabricated microfluidic meander device is the 
concentration of the supplied oxygen in the gas side due to the higher driving force. On 
the other hand, when pure oxygen is supplied to the gas chamber, the influence of 
membrane thickness over the oxygenation process is 1.5 fold higher than the effect 
exerted by the channel width. 
Microfluidic devices for blood oxygenation represent an opportunity for 
decreasing priming volume, which is especially relevant in the case of neonates. Figure 
10 illustrates how the total liquid chamber volume of the meander microdevice changes 
as a function of membrane thickness and blood channel width, when using pure 
oxygen, to guarantee 95% of blood oxygenation at the outlet at 0.1 mL/min blood flow 
rate. In this parametric study, the blood saturation at the oxygenator inlet, the blood 
flow rate and channels depth were established, being 80%, 0.1 mL/min and 100 μm, 
respectively. A total of 30 simulations were performed where five different channel 
widths were examined, i.e. in the range of 100-400 μm, and six membrane thicknesses, 
i.e. in the range of 30-120 μm (see Table S2 in the Supplementary Material for details of 
each simulation). Figure 10 shows, thus, the effect of miniaturization on blood 
oxygenation in the meander designed chip. Considering the low limit for arteriovenous 
pressure drop in neonates is 27 mbar [13], we have set this value as the maximum 
pressure drop in the microdevice. To minimize liquid chamber volume for a given gas 
exchange and blood flow rate, both parameters, membrane thickness and channel 
width, should be minimized as much as is practically possible. The reduction of the 
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membrane thickness and liquid channel width to the set values from the sensitivity 
analysis, i.e. 100 µm, should be done in such a way that the current easy-of-fabrication 
by PDMS-casting & release procedure should not be compromised. Fabrication of a 
thinner membrane (50 µm) within the 100 µm high channels will further improve the 
performance of the oxygenation device. However, various aspects have to be 
considered upon realization and operation of devices. First of all, it might be necessary 
to optimize the plasma bonding parameters [25] to reduce/minimize the risk for 
membrane delamination and thus to obtain a guaranteed membrane integrity in terms 
of engineering. Moreover, lateral membrane deflection can be prevented by balancing 
the liquid and gas flow rates, respectively. By means of modelling, it can be determined 
how much oxygen pressure (thus flow rate) should be applied to the gas channel to: i) 
counteract the pressure in the blood channel as induced by the blood flow; and, ii) to 
avoid the risk of gas bubbles formation in blood (due to pressure-driven convection of 
gas through the membrane). This is not a trivial task due to the fact that the pressure at 
the blood side might vary over time as a consequence of pumping or physiological 
reasons. 
We envision that higher blood volumes can be handled by employing a larger 
number of the microfluidic devices presented here, arranging them in parallel, but 
keeping the functional dimensions of the microchannels and membrane configuration 
the same. The main issue in parallel arrangement of microfluidic networks is in the 
equal distribution of flows over the different elements. Recent work on 3D printed 
microchannel networks for 2D spatial separations may provide a route to cope with this 
problem [27].  
Considering that rated blood flow, defined as the flow rate at which blood with 
an inlet SO2 of 70% is raised to 95% by the device, which is the parameter commonly 
adopted for devices inter-comparison; we have performed an additional simulation 
with the optimized microdevice to increase the oxygen saturation level by 25% at 0.1 
mL/min blood flow rate ensuring low pressure drop. Thus, 21.4 μL. 38.4 μL, 4.1 cm2 and 
8.2 cm2 are the estimated liquid chamber volume, priming volume (including fluidic 
connections and flow distributors), gas exchange surface area and total blood 
contacting area values, respectively for the optimized single unit with 100 µm channel 
width and 100 μm membrane thick (see last row of Table S2 in the Supplementary 
Material).  
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Taking into account the extracorporeal bypass volume of 30 mL·kg-1·min-1 [7], we 
have scaled our oxygenator to a rated blood flow of 60 mL/min which is an approximate 
minimum required for neonate applications. Thus, the gas exchange surface area and 
volume of the liquid chamber for the meander artificial lung with channels 100 μm wide 
and membrane 100 μm thick can theoretically approach to 0.25 m2 and 12.8 mL, i.e. 
600 modules arranged in parallel, to satisfy the oxygenation of a 2.0 kg infant. 
Matharoo et al [13] have recently described the in-vitro and in-vivo oxygenation 
performance of µAL based on stainless steel reinforced composite silicone membranes. 
Based on reported values in [13] using pure oxygen, the gas exchange surface area and 
priming volume for neonates scale to 0.04 m2 and 20 mL at the expense of a high 
pressure drop of 67 mbar. Finally, the predicted volume for the meander type 
microfluidic device is lower than the priming volume (arterial filter excluded) of 
commercial oxygenators for infants based on microporous hollow fibre membrane 
contactors, i.e. 38 and 81 mL respectively for QUADROX-i Neonatal and the QUADROX-i 
Pediatric respectively [28].  
Conclusions 
A simple, compact and easy to fabricate meander type microfluidic device with 
double side gas diffusion property and liquid channels 400 μm wide and 100 μm deep 
has been developed and successfully applied for oxygenation of sheep blood.  
Computer simulations in COMSOL Multiphysics 5.0 have enabled the chip design 
to meet requirements for pressure drop and shear stress. In a step further, the oxygen 
transfer process has been mathematically described to predict the oxygenation 
performance of meander type microdevices. The reasonable agreement between the 
experimental results and the model predictions supports the model validation.  
The blood was successfully oxygenated in the meander microdevice with 2.9 cm2 
of gas exchange surface area up to approximately 93%-98% as a function of the blood 
flow rate ranging from 0.1 to 1 mL/min. The exhibited oxygen transfer rate values were 
in the range of previous publications, up to 92 mL/min·m2 for 3.5 L/min·m2 of blood 
flow rate.  
Theoretical parametric analyses reveal that it is possible to increase the oxygen 
saturation level by 25% at a blood flow rate of 0.1 mL/min and an average pressure 
drop of 22 mbar by reduction of both membrane thickness and channel width up to 100 
μm. Based on our microfabrication experience, the reduction of the membrane 
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thickness and liquid channel width up to 100 μm does not introduce any complexity to 
the easy to fabricate approach based on straightforward PDMS-casting & release. 
Although membrane delamination and/or lateral deflection have to be considered upon 
realization and operation of devices with thinner (or taller) membranes; the integrity of 
the microfluidic chip can be guaranteed through careful engineering. 
Thus, the predicted volume for the liquid chamber of the μAL (excluding fluidic 
connections, transfer lines and flow distributors) to satisfy oxygenation of a 2.0 kg 
infant is 12.8 mL. Such volume is lower in comparison to priming volume of commercial 
oxygenators for infants, and it is within the range of the predicted values for other 
microfluidic oxygenators scaled for rated blood flow [13].  
Our future work [29], inspired from these encouraging results, is focused on the 
fabrication of three-dimensional µALs by 3D printing technology for a more closely 
mimic their natural counterparts. 
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Table 1 
Table 1 Main parameters of the proposed meander vertical-type geometry chip 
Memb 
thick., tm 
[μm] 
Memb 
Area, SA# 
[cm2] 
Liq. 
channel 
width 
[μm] 
Gas 
channel 
width 
[μm] 
Meander 
unit length 
[mm] 
Gas/liq 
channel 
depth 
[μm] 
Liq vol 
[μL] 
Chip 
footprint 
[cm2] 
120 2.9 400 100 2 100 58 35.0 
# Membrane surface area for gas exchange calculated as explained in the Supplementary Material. 
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Table 2 
Table 2 Summary of the main blood and oxygen related parameters  
 
 
  
Parameter Symbol Value Units Ref 
Solubility coefficient of O2 in plasma α 9.37·10-4 mol·m-3·mbar-1 [20] 
Diffusion coefficient of O2 in plasma Db 1.8·10-9 m2·s-1 [20] 
Number of binding sites of Hb n 2.85 - [17] 
Partial pressure of O2 at 50% blood 
saturation* P50 38.7 mbar [17] 
O2 binding capacity of Hb Hbs 1.34·10-6 m3·g-1  
O2 density d 1331 g·m-3  
Blood density ρ 1050 kg·m-3 [20] 
Blood viscosity μ 2.9 10-5 mbar·s [20] 
O2 permeability, PDMS Perm 1.12·10-11# mol·m·m-2·s-1·mbar [26] 
* at 37oC, pH 7.4 and PCO2 of 53.3 mbar;
 # equivalent to 334 Barrer  
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Table 3 
Table 3 Main blood parameters of each oxygenation experiment 
 
 
  
Meander Design with vertical membrane device, MD 
 [Hb] [g/mL] SO2 inlet [%] 
Device 1 0.136 81.4 
Device 2 0.145 83.7 
Device 3 0.141 77.6 
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Figure 1 
 
Figure 1. Schematic representation of the meandering channel arrangement, top view. 
 
  
22 
 
Figure 2 
 
Figure 2. Computer modelling results of the meander design of A) liquid flow velocity, B) pressure 
distribution and C) shear stress for 1 mL/min blood flow rate. (Grey-scale plotting as Figure S2 in 
Supplementary Material).  
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Figure 3  
 
Figure 3. Schematic representation of the A) Cartesian control volume for the derivation of the species 
conservation equation, and B) boundary conditions in the double side oxygen diffusion system. 
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Figure 4 
 
Figure 4. A) and B) SEM images; C) a photograph of a meandering design microfluidic chip and C1) 
magnification of the flow distributors and fluidic connections. Green and red colours indicate gas and 
liquid channels, respectively. 
  
25 
 
Figure 5 
 
Figure 5. Experimental set-up for blood oxygenation experiments. 
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Figure 6 
 
Figure 6. Numerical modelling results for the oxygen concentration profile in the meander device at A) 
0.1 mL/min blood flow rate and B) 1 mL/min blood flow rate; and their respective magnifications 
showing the streamlines plot for the blood velocity. (Grey-scale plotting as Figure S3 in Supplementary 
Material). 
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Figure 7 
            
Figure 7. Comparison between the computationally modelled and experimentally obtained oxygen 
transfer rate values (average ± SD) for the three identical devices (see Table 3 and Table S1) prepared 
for this work.  
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Figure 8 
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Figure 8. Oxygen transfer rate at various liquid flow rates for meander type device, MD, in comparison 
to the leading groups at a blood flow in the range of 0.1-1 mL/min. Empty symbols indicate the 
experiments with pure oxygen as a gas phase, while filled symbols indicate the usage of air. 
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Figure 9 
 
Figure 9. Influence of A) oxygen concentration in the source gas, B) membrane thickness and C) channel 
width in the meander device, on the oxygen transfer rate at different blood flow rates. Inlet saturation, 
SO2 = 80%, parameters for Hill equation see Table 2.  
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Figure 10 
 
Figure 10. A theoretical plot demonstrating the impact of a microfluidic oxygenator device's membrane 
thickness and blood channel width on the liquid chamber volume. PDMS was assumed to be the 
membrane material and pure oxygen was supplied from the gas side. The blood flow rate is 0.1 mL/min 
and the final O2 saturation at the outlet is assumed to be 95%. 
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